markets

POET Technologies jumps after receiving $5 million order for its optical engines from a “leading systems integrator”

POET Technologies is soaring after the optical communications company announced that it has received a more than $5 million order for its POET Infinity optical engines from “a leading systems integrator that will manufacture and sell optical transceiver modules.”

This serves to validate some of the recent retail interest in the company, which is looking to carve out a niche in the AI boom with a suite of offerings that aim to speed the transmission of data in data centers.

POET has generated under $2 million in revenues since the end of 2018, so the order will singlehandedly serve as a massive inflection point for its top line. Management expects to ship these optical engines in the second half of next year.

“I think we’re starting to not be a pre-revenue company soon, and I think as we get into that phase of our business, things will be even better than they are today,” POET Executive Chairman and CEO Dr. Suresh Venkatesan recently told Sherwood News.

Read More: POET Technologies CEO Dr. Suresh Venkatesan on the “sweet spot” for the optical communications company in the AI boom

More Markets

See all Markets

Southwest Airlines At Ronald Reagan Washington National Airport

Southwest’s first full quarter charging for checked bags drives it to record Q3 revenue

Southwest became the third major airline to report its third-quarter earnings when it dropped its results after the bell Wednesday.

Max Knoblauch6h

IBM Q3 Earnings Numbers

IBM slides despite earnings beat

Here’s how Big Blue did.

Matt Phillips6h

markets

J. Edward Moreno6h

Moderna drops after reporting trial for birth defect vaccine failed

Moderna dropped in after-hours trading Wednesday after it reported that its experimental vaccine for cytomegalovirus (CMV), which can cause birth defects, failed in a late-stage trial.

The company is perhaps best known for being tapped by the government to quickly develop a vaccine for COVID-19 in 2020, which remains its single source of revenue. Investors have been eager for signs that it will add more vaccines to its portfolio soon.

The CMV vaccine was the main product in Moderna’s pipeline prior to the COVID-19 pandemic. In the most recent results, the vaccine was only between 6% and 23% effective in blocking infection, which was “well below” the company’s target of at least 49%, the company said in a statement.

In statements announcing the results, Moderna’s leaders described the results at “disappointing.” The company fell more than 5% after-hours and is down more than 35% this year.

Toby Bochan, Luke Kawa

US stocks tumble as momentum trades unwind, earnings disappoint

The S&P 500, Nasdaq 100, and Russell 2000 all ended Wednesday in the red.

Bear Tearing Fabric

markets

Max Knoblauch9h

Carvana plunges as investors respond to another subprime lender’s bankruptcy filing

Used car retailer Carvana is plunging on Wednesday, with the stock on pace for its worst day since auto tariffs took effect in April.

Likely spooking investors is a fresh bankruptcy filing by PrimaLend, which specializes in financing for dealerships focused on subprime borrowers (customers with lower credit scores, typically below 600, as defined by Experian). The news follows last month’s bankruptcy filing by another subprime auto lender, Tricolor Holdings.

Carvana doesn’t appear to work directly with PrimaLend, but it does likely have significant exposure to subprime loans. According to a January report by Hindenburg Research, which was shorting Carvana, 44% of the loans Carvana packages into asset-backed securities (ABS) are classified as nonprime (601-660 credit scores). More than 80% of its recent nonprime ABS deals had average FICO scores in the “deep subprime” range, or the riskiest levels, according to the report. Carvana at the time called the report “intentionally misleading and inaccurate.”

Carvana has massive growth goals, saying earlier this year that it aims to sell 3 million retail units per year within 5 to 10 years. (Wall Street expects it to sell about 580,000 units this year.) Lower-income buyers could be a significant part of that growth.

Following Tricolor’s implosion last month, JPMorgan CEO Jamie Dimon said: “When you see one cockroach, there are probably more. Everyone should be forewarned on this one.” With investors pouring out of Carvana on Tuesday, it seems Wall Street isn’t taking that warning lightly.

There is likely also some momentum pullback baked into Carvana’s drop: the stock, which has been a favorite among retail traders, is still up 58% this year, even after Wednesday’s drop.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC